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The Effect of Caffeic Acid Phenethyl Ester (CAPE)
Treatment on Levels of MDA, NO and Antioxidant
Enzyme Activities in Retinas of Streptozotocin-Induced
Diabetic Rats

Nurten ÖZÇELİK2
Aim: This study was performed to determine the effect of caffeic acid phenethyl ester (CAPE) treatment on
levels of malondialdehyde (MDA) and nitric oxide (NO) and activities of antioxidant enzymes in retinas of
streptozotocin (STZ)-induced diabetic rats.
Materials and Methods: Twenty-seven rats were enrolled and divided into three groups: group 1: nondiabetic rats as control (n = 9); group 2: STZ-induced, untreated diabetic rats (n = 8); and group 3: STZinduced, CAPE-treated diabetic rats (n = 10). Levels of MDA and NO and the activities of superoxide dismutase
(SOD) and glutathione peroxidase (GSH-Px) in retinal tissues were analyzed.
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Results: In retinas of untreated diabetic rats, levels of MDA and NO and the activity of GSH-Px were
significantly increased (P = 0.001, P = 0.0001, P = 0.0001, respectively), while the SOD activity was
significantly decreased (P = 0.021) when compared to the control group. GSH-Px activity in the CAPE-treated
diabetic group was markedly higher than that of the control group (P = 0.0001). MDA and NO levels were
lower (P = 0.005, P = 0.001, respectively) and SOD activity was higher in the CAPE-treated diabetic group
compared to the untreated diabetic group (P = 0.016).
Conclusions: It can be concluded that nitrosative and oxidative stress is increased in the diabetic retina. CAPE
treatment inhibits lipid peroxidation and NO overproduction and regulates SOD enzyme activities in diabetic
rat retinas while it has no effects on GSH-Px activity.
Key Words: Antioxidant enzymes, caffeic acid phenethyl ester, diabetic retinopathy, lipid peroxidation

Streptozotocin ile Diyabet Oluşturulmuş Sıçanlarda Kafeik Asit Fenetil Ester
(CAPE) Tedavisinin Retinadaki MDA, NO Düzeyleri ve Antioksidan Enzim
Aktiviteleri Üzerine Etkileri
Amaç: Bu çalışma, streptozotocin (STZ) ile diyabet oluşturulmuş sıçanlarda, kafeik asit fenetil ester (CAPE)
tedavisinin retinadaki malondialdehit (MDA), nitrik oksit (NO) düzeyleri ve antioksidan enzim aktiviteleri
üzerine etkilerini araştırmak üzere yapıldı.
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Yöntem ve Gereç: Yirmiyedi sıçan çalışmaya alındı ve üç gruba ayrıldı: grup 1: diyabetik olmayan sıçanlar
(kontrol grubu) (N = 9); grup 2: STZ uygulanmış-tedavi uygulanmamış sıçanlar (N = 8); grup 3: STZ
uygulanmış ve CAPE tedavisi verilmiş sıçanlar (N = 10). Bütün grupların retinalarında, MDA ve NO düzeyleri,
superoksit dismutaz (SOD) ve glutatyon peroksidaz (GSH-Px) enzim aktiviteleri analiz edildi.
Bulgular: Kontrol grubu ile kıyaslandığında, tedavi uygulanmamış diyabetik sıçanlarda MDA ve NO düzeyleri
ve GSH-Px aktivitesi artmış ( sırasıyla P = 0.001, P = 0.0001, P = 0.0001), buna karşılık SOD aktivitesi
önemli ölçüde azalmış olarak bulundu (P = 0.021). GSH-Px aktivitesi CAPE tedavisi uygulanmış diyabetik
sıçanlarda, kontrol grubuna göre belirgin ölçüde yüksekti (P = 0.0001). CAPE tedavisi uygulanmış diyabetik
sıçanlarda, tedavi edilmemiş olanlara nazaran MDA ve NO düzeyleri azalmış (sırasıyla P = 0.005, P = 0.001),
SOD aktivitesi artmıştı (P = 0.016).
Sonuç: STZ ile diyabet oluşturulmuş sıçanlarda MDA ve NO düzeyleri ve GSH-Px aktivitesi artmıştı, CAPE
tedavisi ile GSH-Px dışındakiler azalmaktaydı. SOD aktivitesi diyabetik grupta azalmışken, CAPE tedavisi ile
artmaktaydı.

mudurmus@hotmail.com
Anahtar Sözcükler: Antioksidan enzimler, kafeik asit fenetil ester, diyabetik retinopati, lipid peroksidasyonu
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Introduction
Diabetic retinopathy (DR) is a major complication of
diabetes and is a leading cause of blindness. DR has been
considered a microvascular disease and the blood-retinal
barrier breakdown is a hallmark of this disease (1).
Diabetes mellitus is associated with an increased
production of free radicals and consequent oxidative
stress. Oxidative stress-related injury plays important
roles in the development of diabetic complications (2,3).
The majority of free radicals and toxic molecules are
derived from oxygen. The principal free radicals are
•
•
•
superoxide (O2 ), hydroxyl ( OH) and peroxyl (LOO )
radicals, all of which could play a role in DNA damage,
glycation, and protein and lipid modification reactions in
diabetes (4). Malondialdehyde (MDA) is an end product of
lipid peroxidation and an indicator of lipid modification by
free radicals in tissues containing high lipid components
(i.e. the retina in our study). There is a basal release of
nitric oxide (NO) that maintains the retinal blood flow in
the retinal microcirculation (5). In diabetes mellitus, NO
levels in tissues increase and the roles of increased NO in
diabetes pathogenesis range from signal transmission to
cell death (6). Antioxidant enzymes such as superoxide
dismutase (SOD) and glutathione peroxidase (GSH-Px)
are parts of the protective defense mechanism against
oxidative damage. These antioxidant defense mechanisms
are also impaired in diabetes mellitus (7).
Caffeic acid phenethyl ester (CAPE), a flavonoid-like
compound, is one of the major components of honeybee
propolis. CAPE, which has no reported harmful effects on
normal cells (8), has several biological and
pharmacological properties: antioxidant (9), antiinflammatory (10), anti-carcinogenic (11), antiviral (12),
and immunomodulatory (13) activities. CAPE can
completely block production of reactive oxygen species in
human neutrophils and the xanthine/xanthine oxidase
system at a concentration of 10μM (9). The levels of lipid
peroxidation and the activities of antioxidant enzymes
were increased in streptozotocin (STZ)-induced diabetic
rats (14,15). CAPE was shown to inhibit lipooxygenase
activities and suppress lipid peroxidation (15).
We aimed to evaluate the protective effect of CAPE
against oxidative stress in STZ-induced diabetic rat
retinas in this study.
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Materials and Methods
Animal Model
Twenty-seven male Sprague-Dawley rats (11 weeks
old) were used in the study. They were kept in an
environment of controlled temperature (24–26°C),
humidity (55–60%), and controlled photoperiod (12 h
light/dark cycle) during the experiment. A commercial
balanced diet (Hasyem Ltd., Isparta, Turkey) and tap
water were provided ad libitum. All animals received
humane care, in compliance with the present institutional
guidelines. The study was reviewed and approved by the
Local Institutional Ethics Committee.
Experimental Design
Twenty-seven rats were randomly divided into three
groups (each animal placed separately in the stainless-steel
cage) as follows: group 1, non-diabetic control rats (n = 9);
group 2, STZ-induced, untreated diabetic rats (n = 8); and
group 3, STZ-induced, CAPE-treated diabetic rats (n = 10),
which were injected daily with CAPE. CAPE was purchased
from Sigma Chemical Co. (St. Louis, MO, USA) and
administered intraperitoneally (i.p.) at a dose of 10
–1
–1
–1
μmolmL kg day . CAPE was administered 3 days after
the STZ treatment and continued until the time of sacrifice.
STZ dissolved in sodium citrate buffer (pH 4.5) was
administered i.p. at a single dose of 35 mg kg–1 body
weight (15). In control rats, isotonic saline solution (an
equal volume of CAPE) was administered i.p. Blood glucose
levels were measured with an Accu-Chek Active strip test in
a glucometer (Roche Diagnostic, Mannheim, Germany) in
all rats after 3 days of STZ treatment. The animals with
blood glucose level less than 300 mg dl–1 were excluded
from the study. After eight weeks of CAPE treatment, the
rats were anesthetized with an intramuscular (i.m.)
–1
injection of 50 mg kg ketamine hydrochloride (Ketalar,
Eczacibasi, Istanbul, Turkey). All animals were sacrificed
under anesthesia, their eyes enucleated and retinas
carefully isolated. The specimens were harvested and
stored at 20°C until biochemical assays.
Biochemical Procedure
The frozen retinas were homogenized (Ultra Turrax
T25, Germany) (1:10, w/v) in 50 mmol L–1 phosphate
buffer (pH 7.4) and kept in an ice bath. The homogenate
was then centrifuged at 5000g for 30 minutes to remove
debris. The homogenate and supernatant were stored at
20°C in aliquots until used for biochemical assays. The
protein content of the tissue was determined by using the
Lowry method (16).
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Determination of GSH-Px Activity

Determination of MDA
Malondialdehyde (MDA) levels, an indicator of free
radical generation that increases at the end of the lipid
peroxidation, were estimated by the double heating
method of Draper and Hadley (17). The principle of the
method is the spectrophotometric measurement of the
color generated by the reaction of thiobarbituric acid
(TBA) with MDA. The level of MDA is expressed as
nanomoles per gram protein.
Determination of NO Level
Nitric oxide (NO) measurement is very difficult in
biological specimens because it can be readily oxidized to
nitrite (NO2 ) and subsequently to nitrate (NO3 ), which
serve as index parameters of NO production. The method
for determining nitrite and nitrate levels was based on the
Griess reaction (18). Results were expressed as
micromoles per gram protein.
Determination of SOD Activity
Total (Cu–Zn and Mn) SOD (E.C. 1.15.1.1) activity
was determined according to the method of Sun et al.
(19). The principle of the method is based, briefly, on the
inhibition of nitroblue tetrazolium (NBT) reduction by the
xanthine/xanthine oxidase system as a superoxide
generator. Activity was assessed in the ethanol phase of
the supernatant after 1.0 ml ethanol/chloroform mixture
(5/3, v/v) was added to the same volume of sample and
centrifuged. One unit of SOD was defined as the enzyme
amount causing 50% inhibition in the NBT reduction rate.
Activity was expressed as units per gram protein.

Glutathione peroxidase (GSH-Px; E.C. 1.6.4.2)
activity was measured by the method of Paglia and
Valentine (20). The enzymatic reaction in the tube that
contained reduced nicotinamide adenine dinucleotide
phosphate, reduced glutathione, sodium azide and
glutathione reductase was initiated by the addition of
hydrogen peroxide (H2O2), and the change in absorbance
at 340 nm was monitored by a spectrophotometer.
Activity was given in units per gram protein. All samples
were assayed in duplicate.
Statistical Analysis
Data were presented as means ± standard error
(S.E.). The one-way analysis of variance (ANOVA) and
post hoc multiple comparison tests (LSD) were performed
on the data of biochemical variables to examine the
difference among groups. P value of <0.05 was
considered as statistically significant.

Results
Initial and final body weight and final blood glucose
levels of rats are shown in Table 1. Biochemical
parameters are summarized in Table 2. MDA levels in the
retina were increased in untreated diabetic rats when
compared to those of the control and CAPE-treated
diabetic groups (P = 0.001 and P = 0.005, respectively).
In the CAPE-treated group, MDA levels were significantly
lower when compared to untreated diabetic rats and
were not significantly different from those of control

Table 1. Initial and final body weight and final blood glucose levels of rats in control, diabetic, and diabetic + CAPE-treated groups (Mean ± SE).
Mean body weight (g)
at the beginning of the study

Mean body weight (g)
at the end of the study

Mean blood glucose levels (mg/dl)
at the end of the study

1-Control (n = 9)

215 ± 10

296 ± 18

139 ± 09

2-Diabetic (n = 8)

216 ± 05

235 ± 07

385 ± 19

3-Diabetic + CAPE (n = 10)

219 ± 05

209 ± 08

384 ± 26

n.s.

0.002

0.0001

1-3

n.s.

0.0001

0.0001

2-3

n.s.

n.s.

n.s.

P-values
1-2

n: number of rats; n.s.: not significant.
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Table 2. Biochemical parameters of retinas in control, diabetic and CAPE-treated diabetic rats (Mean±SE).
MDA
(nmol/g protein)

NO
(μmol/g protein)

SOD
(U/mg protein)

GSH-Px
(U/g protein)

1- Control (n=9)

22.73±4.58

1.62±0.28

0.14±0.01

0.76±0.02

2-Diabetic (n=8)

47.15±5.15

4.62±0.40

0.11±0.01

2.63±0.23

3-Diabetic+CAPE (n=10)

28.06±3.45

2.45±0.26

0.14±0.01

2.17±0.21

0.001

0.0001

0.021

0.0001

P values
1-2
1-3

NS

NS

NS

0.0001

2-3

0.005

0.0001

0.016

NS

NS: not significant; n: number of rats; MDA: malondialdehyde; NO: nitric oxide; SOD: superoxide dismutase;
GSH-Px: glutathione peroxidase; CAPE: caffeic acid phenethyl ester.

retinas. The levels of NO in retinas of untreated diabetic
rats were higher than those of control and CAPE-treated
diabetic groups (P = 0.0001). NO levels in the CAPEtreated group were not significantly different from those
of the control group.
Superoxide dismutase activities in the untreated
diabetic group were significantly lower than in the control
and CAPE-treated diabetic groups (P = 0.021 and P =
0.016, respectively). There was no significant difference
in SOD activities between the control and CAPE-treated
diabetic rats.
On the other hand, the GSH-Px activities were
significantly lower in the control group compared to both
the untreated and CAPE-treated diabetic rats. The GSHPx activities in the untreated diabetic group were not
significantly different from those of the CAPE-treated
group.

Discussion
Diabetic complications have been linked to the
increased production of free radicals in the tissues (3).
Therefore, tissue antioxidant status is one of the major
factors in determining the development of diabetic
complications (21). The levels of MDA and NO and the
activities of SOD and GSH-Px were determined in retinas
of STZ-induced diabetic rats in this study.
Lipid peroxidation has been suggested to be closely
related to diabetes-induced oxidative stress (2-4) and
528

MDA is a good indicator of the rate of lipid peroxidation
(14,21). In the present study, CAPE treatment effectively
prevented increase in MDA level in the diabetic rat retina
(P = 0.001) and hence retinal lipid peroxidation possibly
through its antioxidant properties. We can say that CAPE
treatment can prevent the lipid peroxidation in STZinduced diabetic rat retinas.
Caffeic acid phenethyl ester possesses wide-ranging
properties such as antioxidant, anti-inflammatory, antiNF-kappaB, anti-cyclooxygenase and anti-lipooxygenase
effects. The preventive effect of CAPE on lipid
peroxidation in the retina can be explained by its oxidative
stress-reducing effect and by its scavenging activity on
superoxide radicals. CAPE markedly scavenges superoxide
anions produced in both enzymatic and nonenzymatic
reactions. In addition, it has been demonstrated that
CAPE prevents the initiation of lipid peroxidation by
scavenging peroxy radicals, and is known to be a more
effective radical scavenger than trolox c, alphatocopherol, and ascorbic acid (22).
In the retinal microcirculation, there is a basal release
of NO that maintains the retinal blood flow. NO can play
either a neuroprotective or a neurotoxic role in diverse
neurodegenerative conditions. It has been suggested that
the pathogenesis of early DR may involve a reduced
bioavailability or diminished production of NO [5]. On the
other hand, hyperglycemia stimulates the production of
advanced glycosylated end products, activates protein
kinase C, and enhances the polyol pathway leading to
increased superoxide anion formation. Superoxide anion
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interacts with NO, forming the potent cytotoxin
peroxynitrite, which attacks various biomolecules in the
vascular endothelium, vascular smooth muscle and
myocardium, leading to cardiovascular dysfunction. The
pathogenetic role of nitrosative stress and peroxynitrite
and downstream mechanisms including poly (ADP-ribose)
polymerase (PARP) activation contribute to the
development and progression of diabetic nephropathy,
retinopathy and neuropathy (23). In our study, NO levels
were markedly increased in the diabetic rat retinas and
this increase was inhibited by CAPE treatment, bringing
NO values to those of the control group. This result
demonstrated that CAPE has an ability to reduce the
nitrosative stress in the diabetic rat retina.
Antioxidant enzymes protect tissues against oxidative
damage. For example, SOD catalyzes the conversion of
superoxide radical to H2O2 and protects the cells against
toxic effects of superoxide radicals. GSH-Px eliminates
H2O2 and lipid hydroperoxides and reduces peroxides by
using reduced glutathione as a hydrogen donor (24). In
the current study, SOD activity was significantly
decreased in untreated diabetic rat retinas. CAPE
treatment enhanced the SOD activity in diabetic rats. Our
result is consistent with the result of Obrosova (25), who
indicated a decrease in SOD activity in the diabetic rat
retina. Reduced antioxidant levels as a result of increased
free radical production in experimental diabetes have
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been shown in several studies (7,25). The retinal GSH-Px
activity was significantly increased in untreated diabetic
and CAPE-treated diabetic rats compared to the controls.
The increased GSH-Px activity in diabetic rats reflects the
increased production of H2O2, in accordance with the
findings of other studies (14,15,26). In the present
study, CAPE treatment did not change the activity of
GSH-Px in the diabetic retina.
It can be concluded that nitrosative and oxidative
stress is increased in the diabetic retina. CAPE treatment
inhibits lipid peroxidation and NO overproduction and
regulates SOD enzyme activities in diabetic rat retinas,
while it has no effects on GSH-Px activity. The protective
role of CAPE might be related with its antioxidant
properties. The results imply that CAPE can be beneficial
to prevent or decrease oxidative and nitrosative stress in
the diabetic retina. However, further studies are needed
to prove the protective effect of CAPE on oxidative stress
in the retina caused by diabetes mellitus.
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